Dave Hill

Dave Hill serves as the VP R&D at Haleon since July 2022, following a similar role at GSK from January 2014 to July 2022. At GSK, contributions included leading significant transformations in the Panadol brand and others, along with building R&D teams and enhancing scientific credibility through innovative strategies. Prior experience includes managing director at NPD Works Limited and various roles at Boots Healthcare International, where Dave Hill developed technical strategies and led multifunctional product development teams. Educational background includes advanced studies at Saïd Business School, MIT Sloan, IMD, and a BSc in Chemistry from the University of Sunderland.